122 results
Page 3 of 7
PREM14C
0enxz7s3whhto19ii3
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-10.4
5k957cvrg5oo 83hn
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
1xblbwkpe7y7r1
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.3
g4p7gdd1y si7ozwv
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.4
p0qwnox 0smd6lv
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.6
4ibj7qjxb6a7b
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-2.1
md2j4rn
13 May 20
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
2fd6up3a5 wb1wk
6 Aug 19
Entry into a Material Definitive Agreement
1:52pm
8-K
EX-10.1
g45ue8gk95hb8cxzd
18 Jul 19
Entry into a Material Definitive Agreement
4:57pm
D
50o3rqoy5qg1fxc8hs
29 May 19
$184.95K in debt / securities to be acquired, sold $184.95K, 36 investors
1:08pm
DEF 14C
whf6wj3 d9jo4z6749c
13 May 19
Information statement
5:14pm
8-K
EX-10.1
4a9r8ev2g6j55vdix
2 May 19
Entry into a Material Definitive Agreement
12:00am
PRE 14C
6vwzj0
30 Apr 19
Preliminary information
3:25pm